This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 May;12(5):256.

doi: 10.1038/nrcardio.2015.44. Epub 2015 Mar 31.

Anticoagulation therapy. Optimal dosages and genotypes for edoxaban therapy

PMID: 25824520
DOI: 10.1038/nrcardio.2015.44

Comment

Anticoagulation therapy. Optimal dosages and genotypes for edoxaban therapy

Karina Huynh. Nat Rev Cardiol. 2015 May.

. 2015 May;12(5):256.

doi: 10.1038/nrcardio.2015.44. Epub 2015 Mar 31.

Author

PMID: 25824520
DOI: 10.1038/nrcardio.2015.44

No abstract available

PubMed Disclaimer

Comment on

Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
Mega JL, Walker JR, Ruff CT, Vandell AG, Nordio F, Deenadayalu N, Murphy SA, Lee J, Mercuri MF, Giugliano RP, Antman EM, Braunwald E, Sabatine MS. Mega JL, et al. Lancet. 2015 Jun 6;385(9984):2280-7. doi: 10.1016/S0140-6736(14)61994-2. Epub 2015 Mar 11. Lancet. 2015. PMID: 25769357 Clinical Trial.
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
Ruff CT, Giugliano RP, Braunwald E, Morrow DA, Murphy SA, Kuder JF, Deenadayalu N, Jarolim P, Betcher J, Shi M, Brown K, Patel I, Mercuri M, Antman EM. Ruff CT, et al. Lancet. 2015 Jun 6;385(9984):2288-95. doi: 10.1016/S0140-6736(14)61943-7. Epub 2015 Mar 11. Lancet. 2015. PMID: 25769361 Clinical Trial.

References

1. Lancet. 2015 Jun 6;385(9984):2280-7 - PubMed
1. Lancet. 2015 Jun 6;385(9984):2288-95 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information